Coexpression of EphB4 and ephrinB2 in Tumour Advancement of Ovarian Cancers

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6604216
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Erythropoietin Promotes Bone Formation Through EphrinB2/EphB4 Signaling

Journal of Dental Research
Dentistry
2015English

Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination

Clinical Cancer Research
Cancer ResearchOncology
2019English

Expression of the Inhibitor of DNA-binding (ID)-1 Protein as an Angiogenic Mediator in Tumour Advancement of Uterine Cervical Cancers

British Journal of Cancer
Cancer ResearchOncology
2008English

Inhibition of EphB4-ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers

Cancer Research
Cancer ResearchOncology
2019English

Converging Evidence for Efficacy From Parallel EphB4-Targeted Approaches in Ovarian Carcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers

Clinical Cancer Research
Cancer ResearchOncology
2004English

Ovarian Tissue Transplantation: Current State and Research Advancement

Current Obstetrics and Gynecology Reports
GynecologyObstetrics
2013English

Progesterone Action in Breast, Uterine, and Ovarian Cancers

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2015English

Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian Cancers

Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy